BioNTech Co-Founders to Launch New mRNA Venture by 2026
BioNTech's co-founders Ugur Sahin and Oezlem Tuereci plan to leave the company by 2026 to establish a new venture focused on mRNA technology. While ensuring BioNTech's existing operations continue smoothly, the move signifies a return to early-stage drug development and exploration of next-generation therapies.